Abstract：
Hepatocellular adenomas are benign liver tumors, more frequently seen in young women with a history of long-standing use of estrogenic hormonal contraception. An acute rupture of these adenomas can be the first sign of symptoms; however, they can be life-threatening. The definitive management of hepatic adenoma is liver resection for those larger than 4 cm as this cutoff size is known to be associated with an exponential risk of harboring malignancy and an increased risk for intratumor bleeding. Once intratumor hemorrhage occurs however, the management of hepatic adenoma becomes much more timely critical. In this study, we describe the use of robotic liver resection for the management of hemorrhagic hepatocellular adenoma in a semi-acute setting. We also include a series of robotic hepatic adenoma resection completed in our hepatobiliary program since 2016, which demonstrated the safety, feasibility, and reproducibility of robotic technique in treating hepatic adenoma.
摘要：
肝细胞腺瘤是良性肝脏肿瘤，更常见于有长期使用雌激素避孕史的年轻女性。这些腺瘤的急性破裂可能是症状的第一个迹象;然而，他们可能会危及生命。肝腺瘤的最终治疗方法是对大于4厘米的患者进行肝切除，因为已知该截止尺寸与携带恶性肿瘤的指数风险和瘤内出血的风险增加有关。然而，一旦发生瘤内出血，肝腺瘤的治疗变得更加及时。在这项研究中,我们描述了在半急性环境中使用机器人肝切除术治疗出血性肝细胞腺瘤。我们还包括自2016年以来在我们的肝胆计划中完成的一系列机器人肝腺瘤切除术，这证明了安全性，可行性,机器人技术治疗肝腺瘤的可重复性。
